Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a randomized, double-blind, multicenter, repeat-dose study of fixed doses of Q8003 12 mg/8 mg given q6hr compared to morphine sulfate 24 mg and oxycodone hydrochloride 16 mg given q6hr for the management of acute moderate to severe postoperative pain for 48 hours following bunionectomy surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Q8003 12 mg/8 mg | Experimental | Combination |
|
| Morphine sulfate 24 mg | Active Comparator | Single component |
|
| Oxycodone HCl 16 mg | Active Comparator | Single component |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Q8003 (morphine sulfate and oxycodone hydrochloride) | Drug | Two Q8003 6 mg/4 mg IR Capsules q6h |
|
| Measure | Description | Time Frame |
|---|---|---|
| Differences in desaturation events per standardized time unit | 48 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Difference in efficacy between Q8003 and its components (morphine and oxycodone) | Changes from baseline in pain intensity | 48 hours |
| Differences in the absence of emesis without the use of an anti-emetic (emesis complete response) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Patricia T. Richards, MD, Ph.D. | QRxPharma Inc. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Investigational site | Anaheim | California | 92801 | United States | ||
| Investigational site |
Not provided
Not provided
Not provided
Not provided
Not provided
| Morphine sulfate | Drug | Two morphine sulfate 12 mg IR capsules q6h |
|
| Oxycodone HCl | Drug | Two oxycodone HCl 8 mg IR Capsules q6h |
|
| 48 hours |
| Owings Mills |
| Maryland |
| 21117 |
| United States |
| Investigational site | Pasadena | Maryland | 21122 | United States |
| Investigational Site | San Antonio | Texas | 78229 | United States |
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| C576454 | MoxDuo |
| D009020 | Morphine |
| D010098 | Oxycodone |
| ID | Term |
|---|---|
| D009022 | Morphine Derivatives |
| D009019 | Morphinans |
| D053610 | Opiate Alkaloids |
| D000470 | Alkaloids |
| D006571 | Heterocyclic Compounds |
| D006572 | Heterocyclic Compounds, Bridged-Ring |
| D006576 | Heterocyclic Compounds, 4 or More Rings |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D010616 | Phenanthrenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D011083 | Polycyclic Compounds |
| D003061 | Codeine |
Not provided
Not provided